Streetbeat News

Revenues

ZVIA

Zevia (NYSE:ZVIA) reported Q4 2023 earnings with a GAAP EPS of $(0.14), meeting analyst consensus estimates. Quarterly sales reached $37.79M, surpassing the $37.35M estimate by 1.18% and marking a 6.87% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:01 pm

KR

Recent analyst evaluations of Kroger (NYSE:KR) show diverse outlooks, with a mix of ratings from bullish to bearish. The average 12-month price target is $50.8, reflecting a 3.67% increase from the previous target of $49.00. Analyst actions include adjustments to ratings and price targets, indicating varying perceptions of Kroger's market position. Kroger, a leading U.S. grocer, faces revenue challenges but demonstrates strong financial performance with exceptional net margin, ROE, and ROA. The company's proposed $25 billion acquisition of Albertsons could significantly impact its market position if approved.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 12:00 pm

M

Macy's has outlined its strategic priorities aimed at boosting growth. These include accelerating luxury segment growth, simplifying and modernizing operations, and reinforcing the Macy's brand. The company targets low-single-digit annual growth in comparable sales across owned, licensed, and marketplace channels.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:00 pm

ITRI

Itron (NASDAQ:ITRI) has been evaluated by 6 analysts over the last three months, showing a diverse range of opinions. Recent assessments indicate a shift towards a more bullish outlook, with the average 12-month price target for Itron now at $83.00, up 18.57% from the previous $70.00. Analyst actions include rating changes and price target adjustments, reflecting an optimistic view on Itron's financial performance, which has shown significant revenue growth, a high net margin, and strong ROE and ROA, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 12:00 pm

PPG

PPG Industries (NYSE:PPG) was analyzed by 7 analysts, showing a mix of sentiments with a slight shift towards neutrality in the last 30 days. The average 12-month price target for PPG is now $157.71, up from $157.00, with individual analyst actions ranging from lowering to raising price targets. PPG, a global coatings producer, shows strong financial health with a market cap above industry average, revenue growth of 3.94%, and high net margin of 2.07%. Analyst ratings reflect varied expectations for PPG's stock performance.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 12:00 pm

SRE

Sempra Energy (NYSE:SRE) reported Q4 adjusted EPS of $1.13, slightly above the $1.12 estimate, but saw a 4.24% decrease from last year's earnings. Sales were $3.49B, missing the $3.87B estimate, yet marked a 1.04% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:58 am

AZO

AutoZone reported a Q2 total company same store sales increase of 1.5% excluding currency impacts, with domestic same store sales rising by 0.3%. International sales saw a significant increase, with a 23.9% rise in the 12-week period and 24.5% over 24 weeks, adjusted to 10.6% and 10.7% respectively when excluding foreign exchange rate fluctuations.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:57 am

ELF

E.L.F. Beauty, Inc. (NYSE:ELF) has opened its first European office in London to expand its international business, following a 119% year-over-year growth in international net sales. The company entered the Italian market in late 2023 and is focusing on color cosmetics, skincare, and international markets for growth. Analyst Korinne Wolfmeyer of Piper Sandler has reiterated an Overweight rating on ELF, raising the forecast to $225 from $212, citing expansion prospects in India and Western Europe. E.L.F. Beauty has also raised its fiscal year 2024 earnings per share and revenue guidance.

Portfolio Pulse from Nabaparna Bhattacharya

February 27, 2024 | 11:57 am

OCN

Ocwen Financial reported its FY23 total revenue at $1.067 billion, an increase from $953.9 million year-over-year. However, the company experienced a net loss of $64 million, while its adjusted pre-tax income was $49 million.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:48 am

SWTX

SpringWorks Therapeutics reported its Q4 earnings, highlighting OGSIVEO net product revenues of $5.4M. The company experienced an EPS loss of $(1.44), compared to $(1.19) year-over-year. Additionally, SpringWorks reported a cash reserve of $662.6M.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:39 am